Evidence map›Paper›PMID 39247493›Full record

ArticleOncology letters2024

First‑line endocrine therapy for hormone receptor positive and HER‑2 negative metastatic breast cancer: A Bayesian network meta‑analysis.

Yi-Cheng Jiang, Jing-Jing Yang, Hai-Tian Zhang, Rui Zhuo, Sebastian De La Roche, Luz Angela Torres-De La Roche, Rudy Leon De Wilde, Jie Dong

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Development and validation of a nomogram for predicting the probability of medication adherence to adjuvant endocrine therapy in breast cancer patients: a predictive modeling study.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yi-Cheng JiangDepartment of Breast Surgery, EUSOMA Certified Breast Center, Guilin Traditional Chinese Medicine Hospital of China, Guilin, Guangxi Zhuang Autonomous Region 541002, P.R. China.
Jing-Jing YangDepartment of Neonates, Guilin People's Hospital, Guilin, Guangxi Zhuang Autonomous Region 541001, P.R. China.
Hai-Tian ZhangDepartment of Breast Disease, Guangxi International Zhuang Medical Hospital, Nanning, Guangxi Zhuang Autonomous Region 530001, P.R. China.
Rui ZhuoDepartment of Breast Surgery, EUSOMA Certified Breast Center, Guilin Traditional Chinese Medicine Hospital of China, Guilin, Guangxi Zhuang Autonomous Region 541002, P.R. China.
Sebastian De La RocheInternational Max Planck Research School in Molecular Biology, Georg-August-University of Gottingen, D-37077 Gottingen, Germany.
Luz Angela Torres-De La RocheDepartment of Gynecology, Pius Hospital, Carl von Ossietzky University, D-26121 Oldenburg, Germany.
Rudy Leon De WildeDepartment of Gynecology, Pius Hospital, Carl von Ossietzky University, D-26121 Oldenburg, Germany.
Jie DongDepartment of Breast Surgery, EUSOMA Certified Breast Center, Guilin Traditional Chinese Medicine Hospital of China, Guilin, Guangxi Zhuang Autonomous Region 541002, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endocrine therapy has become the fundamental treatment option for hormone receptor-positive (HR

Indexed as

Bayesian network meta-analysisendocrine therapyhormone receptor positivemetastatic breast cancerreceptor tyrosine-protein kinase erbB-2-negative

Identifiers

PMID39247493
PMCPMC11378012

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.